Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
DOACs and Drug Interactions in Transplant Patients – JTH
Journal of Thrombosis and Haemostasis (JTH)/LinkedIn
Aug 18, 2026, 13:24

DOACs and Drug Interactions in Transplant Patients – JTH

Journal of Thrombosis and Haemostasis shared a post on LinkedIn about a recent article by Andreas Verstraete et al., adding:

“Direct oral anticoagulant use and drug-drug interactions in transplant recipients receiving calcineurin inhibitors.

Cyclosporine and tacrolimus inhibit the CYP3A4 and P-glycoprotein pathways that clear DOACs, raising concern about elevated drug levels.

Among 216 transplant recipients with 360 DOAC measurements, 11% were above-range, more often with rivaroxaban (20%) and apixaban (18%) than edoxaban (4%).

Higher levels tracked with strong CYP3A4 or P-glycoprotein inhibitors, lower weight, reduced kidney function, and cyclosporine use.”

Title: Direct oral anticoagulant use and drug-drug interactions in transplant recipients receiving calcineurin inhibitors

Authors: Andreas Verstraete, Erwin Dreesen, Quentin Van Thillo, Margot Erard, Dirk R.J. Kuypers, Marc Jacquemin, Filip Rega, Johan Van Cleemput, Jef Verbeek, Robin Vos, Peter Verhamme, Lorenz Van der Linden, Thomas Vanassche

DOACs and Drug Interactions in Transplant Patients - JTH

Other posts about Journal of Thrombosis and Haemostasis on Hemostasis Today.

Andreas Verstraete Dirk R.J. Kuypers DOACs Erwin Dreesen Filip Rega Health Hematology Hemostasis Hemostasis News Hemostasis Today Jef Verbeek Johan Van Cleemput Journal of Thrombosis and Haemostasis JTH Lorenz Van der Linden Marc Jacquemin Margot Erard Medicine Peter Verhamme Quentin Van Thillo Robin Vos Thomas Vanassche thrombosis Transplantation
NewsFeed